It is important with regards to therapeutic application of ex vivo-expanded autologous Treg to investigate whether triggering the VDR pathway also increases Tregs in T cells from patients with type 1 diabetes, similar to what we had shown in human CD3+ T cells from control subjects [22]. This evidence concerns the gene VDR and type 1 diabetes mellitus.